Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia.
Resistance in the sexually transmitted bacterium Mycoplasma genitalium to all recommended therapeutic antimicrobials have rapidly emerged. However, to date, internationally reported resistance surveillance data for M. genitalium strains circulating in Eastern Europe are entirely lacking. The aim of...
Main Authors: | Elena Shipitsyna, Tatiana Rumyantseva, Daniel Golparian, Guzel Khayrullina, Amaya C Lagos, Inna Edelstein, Kai Joers, Jörgen S Jensen, Alevtina Savicheva, Natalia Rudneva, Larisa Sukhanova, Roman Kozlov, Alexander Guschin, Magnus Unemo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5391023?pdf=render |
Similar Items
-
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
by: Gerald L. Murray, et al.
Published: (2017-05-01) -
Prevalence of macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Hong Kong
by: P.C.D. Chan, et al.
Published: (2020-12-01) -
Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007–2014
by: Etienne E. Muller, et al.
Published: (2019-02-01) -
Mycoplasma genitalium in Singapore is associated with Chlamydia trachomatis infection and displays high macrolide and Fluoroquinolone resistance rates
by: Tim Hart, et al.
Published: (2020-04-01) -
Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France
by: Chloé Le Roy, et al.
Published: (2016-09-01)